Trial Details
COMPLETEDBasic Information
| Clinical ID | c1096 |
|---|---|
| Identifier | NCT01458951 |
| Trial Title | A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: tofacitinib|DRUG: Placebo |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Tucson |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-06-12 |
|---|---|
| Primary Completion Date | 2025-05-15 |
| Completion Date | 2025-06-15 |